RavenQuest BioMed Inc. announced earnings results for the first quarter ended January 31, 2019. For the first quarter, the company announced sales was CAD 300,030 compared to CAD 611,395 a year ago. Operating loss was CAD 3.194 million compared to CAD 1.075 million a year ago. Net loss was CAD 3.194 million compared to CAD 1.020 million a year ago. Basic loss per share was CAD 0.03 compared to CAD 0.01 a year ago.